“Defensibility” key for AI-centric small biotechs seeking investment
The number of pharma companies utilising AI across a medicine’s lifecycle is growing rapidly
The number of pharma companies utilising AI across a medicine’s lifecycle is growing rapidly
Klineo plans to expand its AI platform to include all cancers in France by the end of 2024, and eventually other countries and diseases.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
Hyperfine starts enrolment in portable imaging workflow study
Acarix starts clinical workflow study for its AI-powered cardiac diagnostic
Cleerly touts new data for AI cardiovascular software
Moderna’s Phase III Covid-19 vaccine trial meets primary endpoints